Kimura disease: A rare cause of painless lymphadenopathy in South Asia : Journal of Family Medicine and Primary Care

Secondary Logo

Journal Logo

Case Report

Kimura disease: A rare cause of painless lymphadenopathy in South Asia

Rijal, Prabhat; Banjade, Madhav; Kumar, Nirmal; Raina, Rohit; Pathania, Monika; Kant, Ravi

Author Information
Journal of Family Medicine and Primary Care 12(4):p 788-791, April 2023. | DOI: 10.4103/jfmpc.jfmpc_1638_22
  • Open



Kimura disease is a rare chronic inflammatory condition of unknown etiology characterized by painless lymphadenopathy with predominant involvement of the head and neck region, with frequent involvement of the salivary glands.[1,2] This disease entity is rare in India with only 200 cases reported in the world after histopathological diagnosis.[3] Kimura disease was first described by Kim and Szeto in the Chinese literature as “Eosinophilic hyperplastic lymphogranuloma” and has been renamed as Kimura`s disease later on after being published in literature by in 1948. Common age of presentation is between 20 and 40 years with the male preponderance of 3:1[4] Peripheral eosinophilia and serum Immunoglobulin (IgE) levels aid in the diagnosis however confirmatory diagnosis can be made only on histopathology. It is assumed to be an autoimmune reaction to antigenic stimulus for which the treatment is based on anti-inflammatory drugs mainly steroids. Multiple organ involvement has been seen with renal involvement being the deadly one. This case report will make the doctors aware of the consideration of this illness in the differential diagnosis of lymphadenopathy in young adults. High clinical suspicion and early diagnosis prevent patients from getting unnecessary investigations and also aid in the early recovery of the patient.

Case Summary

A 35 years female from a middle-class family in a remote village of Uttarakhand with no addictions or comorbidities, P4L4, presented with insidious onset, gradually progressive, painless neck swellings (Right > left) for 3 months. She developed high-grade fever with chills and rigor for 10 days associated with the burning sensation in the swelling. The fever subsided with over-the-counter medications. She did not have a history of sore throat, cough, chest pain, pain abdomen, dysuria, per vaginal discharge, or altered bowel habits. She developed acute onset pruritic erythematous and maculopapular rashes distributed all over the body for 5 days, not associated with any drug ingestion, exposure to new objects or environment, or jaundice. The pruritus was so intense that there were excoriation marks in different parts of the body that were readily appreciable.

She was admitted from the medicine outpatient department (OPD) for the evaluation of lymphadenopathy with rashes. Her vitals at the presentation were normal except for her temperature which was 101°F. On examination, she had multiple cervical lymph nodes in the cervical area levels Ia, Ib, II, III, IV, and post-auricular nodes, the largest measuring 3*3 cm at level II, non-tender, firm, non-matted, and not fixed to the underlying tissue. [Figure 1] She also had palpable bilateral inguinal lymph nodes of similar consistency and relatively smaller size; however, no genital ulcers were evident. There were bilateral anterior axillary lymph nodes palpable with the size of 2*2 cm. She had erythematous and maculopapular rashes dispersed all over the body, predominantly over the bilateral upper and lower extremities, including the facial area, while the anterior abdomen was relatively less involved [Figure 1].

Figure 1:
Rashes and cervical lymphadenopathy at the time of presentation (Pre-treatment)

Baseline blood investigations revealed leucocytosis with eosinophilia. Serum IgE levels were elevated. However, kidney function was normal [Table 1]. A stool routine examination did not reveal any parasite and Imaging of the chest was also normal. She was initially started on oral antihistaminic after a dermatology consultation. Empirically oral Azithromycin was started considering the likelihood of reactive lymphadenitis. Over the course of treatment, pain in the swelling subsided but there was only minimal decrement in the size of lymph nodes. The rashes settled over the course of 7 days of antihistaminic and the fever also subsided. A lymph node biopsy was done as a part of the etiological workup, and the patient was discharged on oral antihistaminic and followed with a biopsy report in 10 days. The patient reported back in OPD with a biopsy report that was suggestive of Kimura disease [Figure 2].

Table 1:
Figure 2:
Histopathological Examination. (i) 40× magnification. (a) Increased eosinophils admixed with inflammatory cells (lymphocytes and occasional histiocytes). (b) There is also the prominence of plump endothelial cells. (ii) 20× magnification. Image showing preserved nodal architecture

After an opinion from hematology, prednisolone was started in an oral dose of 30 mg per day for 10 days and tapered over the next 2 weeks. Deworming with Ivermectin was done before starting the prednisolone. On follow up the patient was examined for lymph nodes, where the lymph nodes were barely palpable [Figure 3] and the rashes were almost absent.

Figure 3:
Post-treatment resolution of rashes


Kimura disease is a rare disease entity, whose etiology is still not clear. However, it has been postulated that the disease occurs due to the autoimmune response mounted against unknown antigenic stimulus which preferentially stimulates the TH2 cells with resultant production of cytokines like macrophage-colony stimulating factor, tumor necrosis factor (TNF) alpha, interleukin 5 (IL-5), interleukin 6 (IL-6), eotaxin, and regulated upon activation normal T cell expressed and secreted (RANKES). Clonal T-cell proliferation leads to disease occurrence as well as recurrence.[5]

The clinical course is usually benign and self-limited. It can involve organs other than lymph nodes like orbit, eyelid, lacrimal gland, and even kidney. Up to 60% of the patients exhibit renal involvement in the form of extramembranous glomerulonephritis and nephrotic syndrome. Renal involvement is a warning sign.[6] Our case did not show any evidence of renal involvement.

The histological features of Kimura`s disease have been divided into constant, frequent, and rare by Hui et al. The constant features include preserved nodal architecture, florid germinal center hyperplasia, eosinophilic infiltration, and post-capillary venule proliferation. The nodular picture is largely preserved with capsular fibrosis, subcapsular sinusoidal obliteration, and perinodal soft tissues being frequently involved.[7]

The nearest differential of Kimura`s disease is angiolymphoid hyperplasia with eosinophilia (ALHE) with a very small margin of differentiation between the two. Kimura`s disease occurs predominantly in males and Asians with a male predilection. Peripheral eosinophilia and elevated IgE levels are more in favor of Kimura`s disease while ALHE occurs in all racial groups.[8] In contrast to Kimura`s disease, ALHE shows prominent vascular proliferation, forming aggregates or plumps with epithelioid and histiocytoid changes.[9]

Regarding the treatment, oral steroids remain the first-line treatment, which at times may need to be upgraded to a higher immunosuppressant depending upon the response. These drugs suppress the disease activity by inhibiting inflammatory responses. In our case, a short course of steroid therapy has provided a sounding response over a short period of time.


Kimura disease though rare is still an enigma of medical science. The relevance of this case is due to the rarity of disease which mimics neoplastic conditions. Hence, it should be put in differential diagnoses of the patient presenting with painless cervical lymphadenopathy and peripheral eosinophilia. Knowledge of this disease will put physicians in a better condition to diagnose and treat it.


Informed consent has been taken from the patient.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.


1. Ioachim HL, Medeiros LJ. Ioachim's Lymph Node Pathology Lippincott Williams &Wilkins 2009.
2. Abhange RS, Jadhav RP, Jain NK. Kimura disease:A rare case report. Anl Pathol Lab Med 2018;5:C53–5.
3. Rajesh A, Prasanth T, Sirisha VN, Azmi MD. Kimura's disease:A case presentation of postauricular swelling. Niger J Clin Pract 2016;19:827–30.
4. Tseng CF, Lin HC, Huang SC, Su CY. Kimura's disease presenting as bilateral parotid masses. Eur Arch Otorhino Laryngol Head Neck 2005;262:8–10.
5. Meningaud JP, Pitak-Arnnop P, Fouret P, Bertrand JC. Kimura's disease of the parotid region:Report of 2 cases and review of the literature. J Oral Maxillofac Surg 2007;65:134–40.
6. Abhay H, Swapna S, Darshan T, Vishal J, Gautam P. Kimura's disease:A rare cause of local lymphadenopathy. Int J Sci Stud 2014;2:122–5.
7. Chen H, Thompson LD, Aguilera NS, Abbondanzo SL. Kimura disease:A clinicopathologic study of 21 cases. Am J Surg Pathol 2004;28:505–13.
8. Vimal S, Panicker NK, Soraisham P, Chandanwale SS. Kimura disease. Med J Dr. DY Patil Univ 2013;6:208.
9. Swarnkar M, Agrawal A. Kimura's disease. Formos J Surg 2018;51:26.

Kimura; lymphadenopathy; painless

Copyright: © 2023 Journal of Family Medicine and Primary Care